Flow sought to raise awareness of transcranial direct current stimulation (tDCS) as a proven, non-invasive treatment for depression. By showcasing its decade-long clinical success in targeting the neurological roots of psychological disorders, the campaign aimed to educate both patients and healthcare professionals about this innovative therapy. We positioned tDCS as a safe and effective alternative to conventional antidepressants, emphasising its lack of side effects and potential to improve quality of life for those struggling with treatment-resistant depression. This approach broadened understanding and acceptance of emerging mental health solutions.